Advances in AAV-mediated gene transfer for the treatment of inherited disorders

This publication has 50 references indexed in Scilit:

• From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
  Current Gene Therapy, 2003
• Adeno-associated viruses undergo substantial evolution in primates during natural infections
  Proceedings of the National Academy of Sciences, 2003
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
  Proceedings of the National Academy of Sciences, 2002
• The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
  Proceedings of the National Academy of Sciences, 2002
• Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain
  Human Gene Therapy, 2002
• Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease
  Annals of Neurology, 2000
• Parvovirus replication.
  Microbiological Reviews, 1990
• Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus
  Virology, 1986
• Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV
  Published by Elsevier ,1983
• Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.
  Proceedings of the National Academy of Sciences, 1982